171 related articles for article (PubMed ID: 2358467)
1. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
Lyons SD; Sant ME; Christopherson RI
J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
3. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
Kaufman ER
Somat Cell Mol Genet; 1985 Jan; 11(1):1-10. PubMed ID: 3856328
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
Ardalan B; Arakawa M; Villacorte D; Jayaram H; Cooney DA
Biochem Pharmacol; 1982 Apr; 31(8):1509-13. PubMed ID: 6178415
[TBL] [Abstract][Full Text] [Related]
6. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Huber KR; Rosenfeld H; Roberts J
Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
[TBL] [Abstract][Full Text] [Related]
7. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
8. Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells.
Kemp AJ; Lyons SD; Christopherson RI
J Biol Chem; 1986 Nov; 261(32):14891-5. PubMed ID: 3771555
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
Loh E; Kufe DW
Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907
[TBL] [Abstract][Full Text] [Related]
10. Glutamine antagonists in chemotherapy.
Livingston RB; Venditti JM; Cooney DA; Carter SK
Adv Pharmacol Chemother; 1970; 8():57-120. PubMed ID: 4400179
[No Abstract] [Full Text] [Related]
11. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
Lebedeva ZI; Kabanova EA; Berezov TT
Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
[TBL] [Abstract][Full Text] [Related]
12. gamma-Glutamyl hydrolase from human sarcoma HT-1080 cells: characterization and inhibition by glutamine antagonists.
Waltham MC; Li WW; Gritsman H; Tong WP; Bertino JR
Mol Pharmacol; 1997 May; 51(5):825-32. PubMed ID: 9145921
[TBL] [Abstract][Full Text] [Related]
13. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
[TBL] [Abstract][Full Text] [Related]
14. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
Kensler TW; Jayaram HN; Cooney DA
Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
[TBL] [Abstract][Full Text] [Related]
15. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.
Cadman E; Benz C; Heimer R; O'Shaughnessy J
Biochem Pharmacol; 1981 Sep; 30(17):2469-72. PubMed ID: 21043247
[TBL] [Abstract][Full Text] [Related]
16. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
Hofer A; Steverding D; Chabes A; Brun R; Thelander L
Proc Natl Acad Sci U S A; 2001 May; 98(11):6412-6. PubMed ID: 11353848
[TBL] [Abstract][Full Text] [Related]
18. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
Jayaram HN; Cooney DA; Ryan JA; Neil G; Dion RL; Bono VH
Cancer Chemother Rep; 1975; 59(3):481-91. PubMed ID: 1147
[TBL] [Abstract][Full Text] [Related]
19. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
Aoki T; Sebolt J; Weber G
Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
[TBL] [Abstract][Full Text] [Related]
20. Enzyme targets of antiglutamine agents in cancer chemotherapy.
Prajda N
Adv Enzyme Regul; 1985; 24():207-23. PubMed ID: 2424283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
